EXPLANATORY STATEMENT
HEALTH INSURANCE ACT 1973
SECTION 23DNA
HEALTH INSURANCE (ACCREDITED PATHOLOGY LABORATORIES –
APPROVAL) AMENDMENT PRINCIPLES 2008
Section 23DNA of the Health Insurance Act 1973 (the Act) provides for the Minister to
determine the principles to be applied by the Minister in exercising powers under section 23DN of the Act to approve in principle, or not to approve, premises as an accredited pathology laboratory.
Medicare benefits, apart from some basic tests conducted by treating medical practitioners on their own patients, are not payable in respect of pathology services unless they are rendered in an accredited pathology laboratory. The accreditation principles operate to ensure minimum acceptable standards in pathology laboratories. The principles as determined also make reference to National Pathology Accreditation Advisory Council, (NPAAC) accreditation documents, which are standards, guidelines and other assessment aids that must be taken into account during the accreditation process. Medicare Australia administers the accreditation process and the National Association of Testing Authorities, Australia (NATA) conducts the accreditation assessment, in conjunction with the Royal College of Pathologists Australasia (RCPA).
NPAAC has endorsed the following new NPAAC document, which forms part of the Amendments to the Principles 2008 (No.1), Schedule 1 Part 1 of the Principles:
- Requirements for Transfusion Laboratory Practice
The “Requirements for Transfusion Laboratory Practice” is a new NPAAC document. It is based on the recently released Australian and New Zealand Society of Blood Transfusion (ANZSBT) Guidelines for Pretransfusion Laboratory Practice (2007) and incorporates the essential elements of the ANZSBT Guidelines for Blood Grouping and Antibody Screening in Antenatal and Perinatal Settings (2007).
All transfusion laboratories operating in Australia are currently complying with the ANZSBT Guidelines and are assessed by NATA using these Guidelines and other relevant NPAAC Standards. Therefore whilst the adoption of these Guidelines will bring them into force as mandatory NPAAC requirements, their inclusion is expected to have minimal impact on stakeholders as there will be no change to current practice required.
The NPAAC document Requirements for Transfusion Laboratory Practice (2008) will be included in the list of accreditation materials, with an effect date of 1 October 2008.
A copy of the Requirements for Transfusion Laboratory Practice document is available on the NPAAC website – www.health.gov.au/npaac
Consultation
In accordance with the established NPAAC public consultation and drafting process, the draft document was circulated for comments to:
- all laboratories within Australia
- NPAAC members, including State and Territory representatives
- peak pathology industry and professional organisations
The document was also posted on the NPAAC website.
Submissions from the public consultation phase for this document were considered by NPAAC in the finalisation of the document. All issues of concern were resolved through the drafting process and the impact on industry has been assessed as minimal, given the current level of compliance with the existing ANZSBT Guidelines.
Overview
The Health Insurance (Accredited Pathology Laboratories – Approval) Amendment Principles 2008, enacted by the Australian Government, aims to update the criteria for accrediting pathology laboratories under the Health Insurance Act 1973. This legislation addresses the need to ensure that pathology services provided in accredited laboratories meet certain standards, which are essential for the provision of Medicare benefits for pathology services, except for some basic tests performed by medical practitioners on their own patients. The policy objective is to maintain and enhance the quality of pathology services through adherence to nationally recognised standards and guidelines.
The amendment introduces a new document titled "Requirements for Transfusion Laboratory Practice," endorsed by the National Pathology Accreditation Advisory Council (NPAAC). This document, based on the Australian and New Zealand Society of Blood Transfusion Guidelines, aims to standardise transfusion laboratory practices and ensure compliance with current industry standards. The new requirements are expected to have minimal impact on stakeholders as they align with existing practices and guidelines already in use. The amendment follows a thorough consultation process with relevant stakeholders, including laboratories, NPAAC members, and pathology industry organisations, to ensure the new standards are practical and effectively implemented.
Scope and Application
The Health Insurance (Accredited Pathology Laboratories – Approval) Amendment Principles 2008, as specified in Section 23DNA of the Health Insurance Act 1973, applies to entities operating as pathology laboratories in Australia that seek accreditation to provide pathology services eligible for Medicare benefits. This legislation mandates that such laboratories must meet the accreditation principles set forth by the Minister for Health, ensuring that they adhere to the minimum acceptable standards as endorsed by the National Pathology Accreditation Advisory Council (NPAAC). The application of these principles extends to all pathology laboratories across the nation, overseen by Medicare Australia with assessments conducted by the National Association of Testing Authorities, Australia (NATA) in collaboration with the Royal College of Pathologists Australasia (RCPA). The newly endorsed NPAAC document, "Requirements for Transfusion Laboratory Practice," which incorporates ANZSBT Guidelines, is mandatory and will be included in the list of accreditation materials effective from 1 October 2008. This amendment aims to formalise the existing compliance with ANZSBT Guidelines, thereby maintaining consistent standards with minimal impact on current practices.
Key Provisions
Section 23DNA of the Health Insurance Act 1973 (the Act) sets out the principles that the Minister must apply when determining whether to approve premises as an accredited pathology laboratory. These principles are designed to ensure that pathology services rendered in an accredited laboratory meet minimum acceptable standards, which are essential for the proper functioning of the Medicare system. The accreditation process is overseen by Medicare Australia, with the National Association of Testing Authorities, Australia (NATA) conducting the assessments in conjunction with the Royal College of Pathologists Australasia (RCPA).
The obligations imposed by the Act on parties and entities include compliance with the accreditation principles established by the Minister. These principles reference the National Pathology Accreditation Advisory Council (NPAAC) accreditation documents, which encompass standards, guidelines, and other assessment aids that must be adhered to during the accreditation process. Accredited laboratories are required to meet these standards to ensure the quality and safety of pathology services, which in turn allows for the provision of Medicare benefits for these services.
There are no specific offences, penalties, or consequences outlined in the provided explanatory statement for breaches of the accreditation requirements under Section 23DNA. However, it is implied that failure to comply with the accreditation principles could result in the non-approval of premises as an accredited pathology laboratory. This non-approval would prevent the laboratory from rendering pathology services that are eligible for Medicare benefits, which could have significant financial and operational implications for the laboratory. Furthermore, ongoing non-compliance with accreditation standards could potentially lead to further regulatory actions by Medicare Australia or NATA.